Allogeneic ABCB5-positive Stem Cells for Treatment of PAOD
Status:
Terminated
Trial end date:
2020-05-15
Target enrollment:
Participant gender:
Summary
The aim of this clinical trial is to investigate the efficacy (by monitoring the wound size
reduction of Peripheral Arterial Occlusive Disease-related clinically relevant ulcers) and
safety (by monitoring adverse events) of one dose of allo-APZ2-PAOD administered
intramuscularly into an affected lower leg of patients with Peripheral Arterial Occlusive
Disease.